Stock A089140 NEXTURNBIOSCIENCE CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News NEXTURNBIOSCIENCE Co., Ltd.

Equities

A089140

KR7089140008

End-of-day quote Korea S.E.
Other stock markets
 03:30:00 17/05/2024 am IST 		5-day change 1st Jan Change
4,080 KRW -0.49% Intraday chart for NEXTURNBIOSCIENCE Co., Ltd. +1.24% -26.09%
21/03 NEXTURNBIOSCIENCE Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 NEXTURNBIOSCIENCE Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
NEXTURNBIOSCIENCE Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
NEXTURNBIOSCIENCE Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Mirae Corporation announced that it has received KRW 2.6 billion in funding from NEXTURNBIOSCIENCE Co., Ltd., UA Co.,Ltd
CI
Mirae Corporation announced that it has received KRW 10 billion in funding from NEXTURNBIOSCIENCE Co., Ltd.
CI
NEXTURNBIOSCIENCE Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
NEXTURNBIOSCIENCE Co., Ltd. announced that it has received KRW 7 billion in funding from Flask Co., Ltd., GLK Equity Investment Co., Ltd., SAMSUNG PHARM. Co., LTD., CMG Pharmaceutical Co., Ltd.
CI
NexturnBioScience Plans 1 Billion Won Capital Raise through Stock Offering; Shares Jump 4%
MT
NEXTURNBIOSCIENCE Co., Ltd. announced that it has received KRW 5.9999959 billion in funding
CI
NEXTURNBIOSCIENCE Co., Ltd. completed the acquisition of 10.59% stake in Mirae Corporation from KANGLIM Co., Ltd.
CI
Mirae Corporation announced that it expects to receive KRW 5 billion in funding from NEXTURNBIOSCIENCE Co., Ltd., UA Co.,Ltd
CI
Mirae Corporation announced that it expects to receive KRW 15 billion in funding from NEXTURNBIOSCIENCE Co., Ltd.
CI
Mirae Corporation announced that it expects to receive KRW 15 billion in funding from NEXTURNBIOSCIENCE Co., Ltd.
CI
NEXTURNBIOSCIENCE Co., Ltd. agreed to acquire a 10.59% stake in Mirae Corporation from KANGLIM Co., Ltd.
CI
NEXTURNBIOSCIENCE Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
NEXTURNBIOSCIENCE Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
NEXTURNBIOSCIENCE Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
NEXTURNBIOSCIENCE Co., Ltd. cancelled the transaction announced on March 31, 2022
CI
NEXTURNBIOSCIENCE Co., Ltd.(KOSDAQ:A089140) dropped from S&P Global BMI Index
CI
NEXTURNBIOSCIENCE Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
NEXTURNBIOSCIENCE Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A089140 Stock
  4. News NEXTURNBIOSCIENCE Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW